BioCentury
ARTICLE | Finance

Regulatory milestones

Regulatory, clinical and other milestones

October 7, 2013 7:00 AM UTC

AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX) gained $0.37 to $10.96 last week after submitting an NDA to FDA for Zalviso sufentanil sublingual microtablet system to manage moderate to severe acute pain in a hospital setting. The company submitted the application under section 505(b)(2) of the Food, Drug and Cosmetic Act.

Anacor Pharmaceuticals Inc. (NASDAQ:ANAC) jumped $2 (20%) to $12.17 last week after FDA accepted an NDA for tavaborole to treat onychomycosis. The PDUFA date is July 29...